Vehreschild, Jörg Janne 1978-
Jörg Janne Vehreschild researcher
VIAF ID: 95653335 (Personal)
Permalink: http://viaf.org/viaf/95653335
Preferred Forms
4xx's: Alternate Name Forms (6)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Age and comorbidity burden of patients critically Ill with COVID-19 affect both access to and outcome of ventilation therapy in intensive care units | |
Akustische Signale in der Diagnostik der pharyngealen Dysphagie | |
Antibiotika als Risikofaktoren für nosokomiale Blutstrominfektionen mit selektionierten Erregern eine Fall-Kontroll-Studie | |
Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways | |
Development and validation of a simplified risk score for the prediction of critical COVID‐19 illness in newly diagnosed patients | |
Development of interoperable, domain-specific extensions for the German Corona Consensus (GECCO) COVID-19 research dataset using an interdisciplinary, consensus-based workflow | |
Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany | |
First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” | |
Hospitalized patients dying with SARS-CoV-2 infection - an analysis of patient characteristics and management in ICU and general ward of the LEOSS registry | |
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 | |
Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis : a retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals | |
Machine learning based prediction of COVID-19 mortality suggests repositioning of anticancer drug for treating severe cases | |
Plasmakonzentrationen von Piperacillin-Tazobactam bei Patienten mit maligner Grunderkrankung : eine Beobachtungsstudie | |
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning | |
Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform | |
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody | |
Risikofaktoren und der Einfluss einer antibiotischen Fluorchinolonprophylaxe auf die Entwicklung von intestinalen Graft-versus-Host-Erkrankungen sowie das Ein-Jahres-Überleben nach allogener Stammzelltransplantation | |
Rozpoznawanie i leczenie powikłań żołądkowo-jelitowych u chorych na nowotwory : zalecenia Deutsche Gesellschaft für Hämatologie und Oncologie (DGHO), (2012 r.) = Diagnosis and management of gastrointestinal complications in adult cancer patients : evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) | |
Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017 |